Heparin resistance in acute coronary syndromes-Reference-Cited by-同舟云学术

Heparin resistance in acute coronary syndromes

Published:2007-01-13 Issue:2 Volume:23 Page:93-100
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Rich Jonathan D.,Maraganore John M.,Young Edward,Lidon Rosa-Maria,Adelman Burt,Bourdon Paul,Charenkavanich Supoat,Hirsh Jack,Theroux Pierre,Cannon Christopher P.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-006-9049-9.pdf

Reference34 articles.

1. Hirsh J (1991) Heparin. The New England J Med 324(22):1565–1574

2. Young E, Prins M, Levine MN, Hirsh J (1992) Heparin binding to plasma proteins, an important mechanism for heparin resistance. Thromb Haemostasis 67(6):639–643

3. Warkentin TE, Greinacher A (2004) Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(3 suppl):311S–337S

4. Horne MK 3rd, Hutchison KJ (1998) Simultaneous binding of heparin and platelet factor–4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia. Am J Hematol 58(1):24–30

5. Young E, Wells P, Holloway S, Weitz J, Hirsh J (1994) Ex-vivo and in-vitro evidence that low molecular weight heparins exhibit less binding to plasma proteins than unfractionated heparin. Thrombosis Haemostasis 71(3):300–304

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Percutaneous coronary intervention in a patient with heparin resistance due to essential thrombocythaemia: a case report;European Heart Journal - Case Reports;2021-02-28

2. Heparin during endovascular stroke treatment seems safe;Journal of Neuroradiology;2019-11

3. Effect of Fixed-Bolus (5,000 Units) Unfractionated Heparin Before Primary Percutaneous Coronary Intervention on Activated Clotting Time, Time Flow, and All-Cause Mortality;The American Journal of Cardiology;2017-01

4. Heparin and anticoagulation;Frontiers in Bioscience;2016

5. Achievement of Therapeutic Anti-Xa Levels in a Proven Heparin-Resistant Patient Through the Use of Nontraditional High-Dose Enoxaparin;Annals of Pharmacotherapy;2014-10-06